Success Story: Advancing Machine Learning for Precise Cancer Cell Identification: NIW Approval Secured for an Artificial Intelligence Researcher from Iran
Client’s Testimonial:
“Working with this team on my EB-2 NIW petition was a great experience. They took the time to understand my research in machine learning and cancer cell identification and presented it in a clear and compelling way. Even though the process took a long time, they kept me informed at every step and guided me through upgrading to premium processing. I'm thankful for their hard work and would gladly recommend them.”
On October 2nd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Research Assistant in the field of Artificial Intelligence (Approval Notice).
General Field: Artificial Intelligence
Position at the Time of Case Filing: Graduate Research Assistant
Country of Origin: Iran
State of Residence at the Time of Filing: Texas
Approval Notice Date: October 2nd, 2026
Processing Time: 2 years, 6 months, 7 days (Premium Processing Requested)
Case Summary:
We are pleased to share the NIW approval of an artificial intelligence researcher whose proposed endeavor focuses on applying machine learning to the precise identification of individual cancer cell types. Through advanced clustering techniques, statistical tools, and data analysis, the client aims to improve understanding of cancer pathology and support the development of more personalized and effective treatment strategies. At the time of filing, the client was conducting research at a U.S. university, where his work involved developing computational methods for identifying rare cell populations within complex biological datasets.
Research with National Importance
The client’s endeavor addresses challenges in cancer research by using artificial intelligence to improve the identification and analysis of distinct cell types. More precise characterization of cancer cells can contribute to better understanding of tumor heterogeneity, disease progression, and individualized treatment approaches. The petition connected this work to U.S. interests in cancer care, public health, artificial intelligence, machine learning, bioinformatics, and predictive modeling, while also noting the importance of these areas to continued U.S. technological leadership.
Academic Contributions and Recognition
At the time of filing, the client had documented his research in 1 peer-reviewed journal article, 2 peer-reviewed conference articles, including 1 first-authored paper, and 1 first-authored conference abstract. His published work had received 20 citations. The petition demonstrated the significance of his research by showing that independent researchers had relied on his prior methods and findings in studies involving artificial intelligence, renewable energy systems, advanced communications, and biomedical research.
The petition further showed that two of the client’s papers ranked among the top 10% most-cited Engineering articles for their respective years of publication. His prior research also demonstrated experience applying artificial intelligence and data-driven methods to complex technical and biomedical problems, including work involving intelligent control systems, sustainable energy technologies, and cell-type analysis. This record, together with documented independent use of his work and support for his biomedical research from major U.S. research agencies, was presented as evidence that he was well positioned to advance his proposed endeavor.
Recognition from Experts
Experts in the field also recognized the significance of the client’s prior biomedical research and its potential to improve understanding of complex health conditions.
One expert noted:
“By delving into the intricate world of non-neuronal cells in the TG, his research contributes to advancing our understanding of complex cellular interactions within the nervous system, aligning with broader goals of enhancing healthcare outcomes and improving the quality of life for individuals affected by sensory disorders.”
This assessment further demonstrates how the client’s prior biomedical research helped establish his ability to apply analytical approaches to complex biological questions, supporting his continued work at the intersection of artificial intelligence and healthcare.
NIW Approval and Outlook
The petition sought EB-2 NIW classification based on the client’s advanced degree and presented his education, research experience, publication and citation record, demonstrated research influence, and continued work in artificial intelligence to establish that he satisfied the Matter of Dhanasar framework.
The I-140 NIW petition was filed on March 25th, 2024, later upgraded to Premium Processing, and approved on October 2nd, 2026. This outcome supports the client’s continued efforts to develop machine learning approaches that can improve biological data analysis and contribute to more precise and individualized strategies for cancer research and treatment.

